Search hospitals > Georgia > Atlanta
Emory University School of Medicine
Claim this profileAtlanta, Georgia 30322
Global Leader in Human Immunodeficiency Virus Infection
Global Leader in Syndrome
Conducts research for Depression
Conducts research for Kidney Disease
Conducts research for Heart Failure
295 reported clinical trials
22 medical researchers
Summary
Emory University School of Medicine is a medical facility located in Atlanta, Georgia. This center is recognized for care of Human Immunodeficiency Virus Infection, Syndrome, Depression, Kidney Disease, Heart Failure and other specialties. Emory University School of Medicine is involved with conducting 295 clinical trials across 364 conditions. There are 22 research doctors associated with this hospital, such as Jane L Meisel, Sagar Lonial, MD, Muna Qayed, MD, MS, and Arezou Khosroshahi.Top PIs
Jane L MeiselWinship Cancer Institute / Emory University School of Medicine1 year of reported clinical research
Expert in Breast Cancer
Studies Cancer
11 reported clinical trials
24 drugs studied
Sagar Lonial, MDThe Winship Cancer Institute of Emory University3 years of reported clinical research
Studies Multiple Myeloma
Studies Plasma Cell Neoplasms
10 reported clinical trials
20 drugs studied
Muna Qayed, MD, MSChildren's Healthcare of Atlanta8 years of reported clinical research
Studies Acute Lymphoblastic Leukemia
Studies Lymphoblastic Leukemia-Lymphoma
10 reported clinical trials
17 drugs studied
Arezou KhosroshahiEmory University1 year of reported clinical research
Studies Systemic Lupus Erythematosus
Studies Lupus
9 reported clinical trials
20 drugs studied
Clinical Trials running at Emory University School of Medicine
Breast Cancer
Parkinson's Disease
Chronic Kidney Disease
COVID-19
Ulcerative Colitis
Bladder Cancer
Solid Tumors
Spinal Cord Injury
Syndrome
Cardiovascular Disease
Lasofoxifene and Abemaciclib vs Fulvestrant and Abemaciclib
for Breast Cancer
The goal of this clinical trial is to assess the efficacy, safety and tolerability of the combination of lasofoxifene and abemaciclib compared to fulvestrant and abemaciclib for the treatment of pre- and postmenopausal women and men who have previously received ribociclib or palbociclib-based treatment and have locally advanced or metastatic estrogen receptor positive (ER+)/human epidermal growth factor 2 negative (HER2-) breast cancer with an estrogen receptor 1 (ESR1) mutation. The main question the study aims to answer is: • To compare the efficacy of the combination of lasofoxifene and abemaciclib with that of fulvestrant and abemaciclib Participants will receive either receive 5 mg/d of oral lasofoxifene plus oral abemaciclib 150 mg twice a day or the combination of fulvestrant 500 mg intramuscular (IM) on Days 1, 15, and 29 and then once monthly thereafter plus oral abemaciclib 150 mg twice a day.
Recruiting2 awards Phase 312 criteria
DS-1103a + T-DXd
for Advanced Cancer
This study will evaluate the safety and efficacy of DS-1103a combination therapy in patients with advanced solid tumors.
Recruiting1 award Phase 1
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Emory University School of Medicine?
Emory University School of Medicine is a medical facility located in Atlanta, Georgia. This center is recognized for care of Human Immunodeficiency Virus Infection, Syndrome, Depression, Kidney Disease, Heart Failure and other specialties. Emory University School of Medicine is involved with conducting 295 clinical trials across 364 conditions. There are 22 research doctors associated with this hospital, such as Jane L Meisel, Sagar Lonial, MD, Muna Qayed, MD, MS, and Arezou Khosroshahi.